Cargando…
A cyclodextrin formulation to improve use of the anesthetic tribromoethanol (Avertin(®))
OBJECTIVE: Efficacy and safety concerns have been raised in the literature with the use of tribromoethanol (TBE) (Avertin(®)) for anesthesia in rats and mice when administered by intraperitoneal (IP) injection. Despite the controversy, it remains in common usage as an anesthetic agent in laboratory...
Autores principales: | McDowell, Arlene, Fothergill, Jessica A., Khan, Azeem, Medlicott, Natalie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895288/ https://www.ncbi.nlm.nih.gov/pubmed/24459399 http://dx.doi.org/10.4103/0975-7406.124303 |
Ejemplares similares
-
Kinetics of proinflammatory cytokines after intraperitoneal injection of tribromoethanol and a tribromoethanol/xylazine combination in ICR mice
por: Cho, Yoon Ju, et al.
Publicado: (2011) -
Avertin Rectal Narcosis
por: Poduval, A. R.
Publicado: (1929) -
Designing a Formulation of the Nootropic Drug Aniracetam Using 2-Hydroxypropyl-β-Cyclodextrin Suitable for Parenteral Administration
por: Goldsmith, Sebastian D., et al.
Publicado: (2018) -
An Experience with Avertin Anæsthesia in Gynæcology
por: Young, James
Publicado: (1930) -
Comparison of the anesthetic effects of 2,2,2-tribromoethanol on ICR mice derived from three different sources
por: Lee, Mi Ree, et al.
Publicado: (2018)